Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Research Article

Reduction of Resting Energy Expenditure and Sarcopenic Obesity in Adults with Overweight and Obesity: A Brief Report

Author(s): Hana Tannir, Dima Kreidieh, Leila Itani, Dana El Masri and Marwan El Ghoch*

Volume 16, Issue 4, 2020

Page: [376 - 380] Pages: 5

DOI: 10.2174/1573399815666191030092138

Price: $65

Abstract

Background and Aim: The last decade has seen the emergence of a new condition, describing the coexistence of obesity and sarcopenia, termed Sarcopenic Obesity (SO). The aim of this study was to assess the potential association between SO and reduced Resting Energy Expenditure (REE).

Methods: Body composition and REE were measured using a bioimpedance analyser (Tanita BC-418) and Indirect Calorimeter (Vmax Encore 229), respectively in 89 adults with overweight or obesity of both genders, referred to the Outpatient Clinic of the Department of Nutrition and Dietetics at Beirut Arab University (Lebanon). Participants were then categorized on the basis of having SO or not.

Results: Thirty-nine of the 89 participants met the criteria for SO (43.8%), and these participants displayed a significantly lower REE per unit body weight than those in the group without SO (19.02 ± 2.26 vs. 20.87 ± 2.77; p = 0.001). Linear regression analysis showed that the presence of SO decreases REE by 1.557 kcal/day for each kg of body weight (β = -1.557; CI = -0.261 – (-0.503); p = 0.004), after adjusting for age and gender.

Conclusion: SO appears to be present in a high proportion of treatment-seeking adults with overweight or obesity of both genders, and it seems to be associated with a reduced REE, compared with those without SO. Future studies are needed to clarify whether this may influence clinical outcomes.

Keywords: Body composition, obesity, sarcopenic obesity, resting energy expenditure, REE, reduced lean body mass.

[1]
El Ghoch M, Calugi S, Dalle Grave R. Sarcopenic obesity: definition, health consequences and clinical management. Open Nutr J 2018; 12: 70-3.
[http://dx.doi.org/10.2174/1874288201812010070]
[2]
Khazem S, Itani L, Kreidieh D, et al. Reduced lean body mass and cardiometabolic diseases in adult males with overweight and obesity: a pilot study. Int J Environ Res Public Health 2018; 15(12): 15.
[http://dx.doi.org/10.3390/ijerph15122754] [PMID: 30563167]
[3]
Kreidieh D, Itani L, El Masri D, Tannir H, Citarella R, El Ghoch M. Association between sarcopenic obesity, type 2 diabetes, and hypertension in overweight and obese treatment-seeking adult women. J Cardiovasc Dev Dis 2018; 5(4): 5.
[http://dx.doi.org/10.3390/jcdd5040051] [PMID: 30347794]
[4]
Khadra D, Itani L, Tannir H, Kreidieh D, El Masri D, El Ghoch M. Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: A systematic review and meta-analysis. World J Diabetes 2019; 10(5): 311-23.
[http://dx.doi.org/10.4239/wjd.v10.i5.311] [PMID: 31139318]
[5]
Hamer M, Batty GD, Kivimaki M. Sarcopenic obesity and risk of new onset depressive symptoms in older adults: English Longitudinal Study of Ageing. Int J Obes 2015; 39(12): 1717-20.
[http://dx.doi.org/10.1038/ijo.2015.124] [PMID: 26122029]
[6]
Atkins JL, Wannamethee SG. The effect of sarcopenic obesity on cardiovascular disease and all-cause mortality in older people. Rev Clin Gerontol 2015; 25: 86-97.
[http://dx.doi.org/10.1017/S0959259815000076]
[7]
Bouchonville MF, Villareal DT. Sarcopenic obesity: how do we treat it? Curr Opin Endocrinol Diabetes Obes 2013; 20(5): 412-9.
[http://dx.doi.org/10.1097/01.med.0000433071.11466.7f] [PMID: 23974769]
[8]
Barazzoni R, Bischoff SC, Boirie Y, et al. Sarcopenic obesity: Time to meet the challenge. Clin Nutr 2018; 37(6 Pt A): 1787-93.
[http://dx.doi.org/10.1016/j.clnu.2018.04.018] [PMID: 29857921]
[9]
Pinheiro Volp AC, Esteves de Oliveira FC, Duarte Moreira Alves R, Esteves EA, Bressan J. Energy expenditure: components and evaluation methods. Nutr Hosp 2011; 26(3): 430-40.
[PMID: 21892558]
[10]
Weigle DS. Appetite and the regulation of body composition. FASEB J 1994; 8(3): 302-10.
[http://dx.doi.org/10.1096/fasebj.8.3.8143936] [PMID: 8143936]
[11]
Siervo M, Oggioni C, Lara J, et al. Age-related changes in resting energy expenditure in normal weight, overweight and obese men and women. Maturitas 2015; 80(4): 406-13.
[http://dx.doi.org/10.1016/j.maturitas.2014.12.023] [PMID: 25616780]
[12]
Carneiro IP, Elliott SA, Siervo M, et al. Is Obesity Associated with Altered Energy Expenditure? Adv Nutr 2016; 7(3): 476-87.
[http://dx.doi.org/10.3945/an.115.008755] [PMID: 27184275]
[13]
Hirsch KR, Smith-Ryan AE, Blue MN, Mock MG, Trexler ET, Ondrak KS. Metabolic characterization of overweight and obese adults. Phys Sportsmed 2016; 44(4): 362-72.
[http://dx.doi.org/10.1080/00913847.2016.1248222] [PMID: 27737609]
[14]
El Ghoch M, Fakhoury R. Challenges and new directions in obesity management: Lifestyle modification programmes, pharmacotherapy and bariatric surgery. J Popul Ther Clin Pharmacol 2019; 26(2): e1-4.
[PMID: 31577079]
[15]
Frankenfield DC, Ashcraft CM, Wood C, Chinchilli VM. Validation of an indirect calorimeter using n-of-1 methodology. Clin Nutr 2016; 35(1): 163-8.
[http://dx.doi.org/10.1016/j.clnu.2015.01.017] [PMID: 25707909]
[16]
El Ghoch M, Calugi S, Dalle Grave R. Weight cycling in adults with severe obesity: A longitudinal study. Nutr Diet 2018; 75(3): 256-62.
[http://dx.doi.org/10.1111/1747-0080.12387] [PMID: 29114979]
[17]
Kelly J, Metcalfe J. Validity and reliability of body composition analysis using the tanita bc418-ma. J Exercise Physiol 2012; 15: 74-86.
[18]
Lee L, Hsieh K, Wu C, Chen Y, Chiang J, Chen Y. Validity of standing posture eight-electrode bioelectrical impedance to estimate body composition in taiwanese elderly. Int J Gerontol 2014; 8: 137-42.
[http://dx.doi.org/10.1016/j.ijge.2013.08.010]
[19]
Oh C, Jho S, No JK, Kim HS. Body composition changes were related to nutrient intakes in elderly men but elderly women had a higher prevalence of sarcopenic obesity in a population of Korean adults. Nutr Res 2015; 35(1): 1-6.
[http://dx.doi.org/10.1016/j.nutres.2014.07.018] [PMID: 25524331]
[20]
Johnson Stoklossa CA, Sharma AM, Forhan M, Siervo M, Padwal RS, Prado CM. Prevalence of sarcopenic obesity in adults with class ii/iii obesity using different diagnostic criteria. J Nutr Metab 2017; 20177307618
[http://dx.doi.org/10.1155/2017/7307618] [PMID: 28421144]
[21]
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the european working group on sarcopenia in older people. Age Ageing 2010; 39(4): 412-23.
[http://dx.doi.org/10.1093/ageing/afq034] [PMID: 20392703]
[22]
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48(1): 16-31.
[http://dx.doi.org/10.1093/ageing/afy169] [PMID: 30312372]
[23]
Solem RC. Limitation of a cross-sectional study. Am J Orthod Dentofacial Orthop 2015; 148(2): 205.
[http://dx.doi.org/10.1016/j.ajodo.2015.05.006] [PMID: 26232823]
[24]
Petroni ML, Caletti MT, Dalle Grave R, Bazzocchi A, Aparisi Gómez MP, Marchesini G. Prevention and treatment of sarcopenic obesity in women. Nutrients 2019; 11(6): 11.
[http://dx.doi.org/10.3390/nu11061302] [PMID: 31181771]
[25]
Coppini LZ, Waitzberg DL, Campos AC. Limitations and validation of bioelectrical impedance analysis in morbidly obese patients. Curr Opin Clin Nutr Metab Care 2005; 8(3): 329-32.
[http://dx.doi.org/10.1097/01.mco.0000165013.54696.64] [PMID: 15809537]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy